vs
Side-by-side financial comparison of Anika Therapeutics, Inc. (ANIK) and Dominari Holdings Inc. (DOMH). Click either name above to swap in a different company.
Dominari Holdings Inc. is the larger business by last-quarter revenue ($30.1M vs $29.6M, roughly 1.0× Anika Therapeutics, Inc.). On growth, Dominari Holdings Inc. posted the faster year-over-year revenue change (220.4% vs 13.2%). Over the past eight quarters, Dominari Holdings Inc.'s revenue compounded faster (369.1% CAGR vs -1.8%).
ANIK vs DOMH — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $29.6M | $30.1M |
| Net Profit | — | $-131.8M |
| Gross Margin | 64.2% | — |
| Operating Margin | 17.3% | -8.9% |
| Net Margin | — | -438.1% |
| Revenue YoY | 13.2% | 220.4% |
| Net Profit YoY | — | -12426.2% |
| EPS (diluted) | $0.27 | $-6.94 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $29.6M | — | ||
| Q4 25 | $30.6M | $30.1M | ||
| Q3 25 | $27.8M | $50.8M | ||
| Q2 25 | $28.2M | $34.1M | ||
| Q1 25 | $26.2M | $8.1M | ||
| Q4 24 | $30.6M | $9.4M | ||
| Q3 24 | $29.6M | $4.0M | ||
| Q2 24 | $30.7M | $6.2M |
| Q1 26 | — | — | ||
| Q4 25 | $292.0K | $-131.8M | ||
| Q3 25 | $-2.3M | $125.2M | ||
| Q2 25 | $-4.0M | $16.6M | ||
| Q1 25 | $-4.9M | $-32.5M | ||
| Q4 24 | $-21.9M | $1.1M | ||
| Q3 24 | $-29.9M | $-4.2M | ||
| Q2 24 | $-88.0K | $-6.1M |
| Q1 26 | 64.2% | — | ||
| Q4 25 | 62.6% | — | ||
| Q3 25 | 56.0% | — | ||
| Q2 25 | 50.9% | — | ||
| Q1 25 | 56.1% | — | ||
| Q4 24 | 56.0% | — | ||
| Q3 24 | 65.7% | — | ||
| Q2 24 | 66.7% | — |
| Q1 26 | 17.3% | — | ||
| Q4 25 | 2.1% | -8.9% | ||
| Q3 25 | -11.6% | -3.1% | ||
| Q2 25 | -14.8% | -57.0% | ||
| Q1 25 | -16.4% | -394.6% | ||
| Q4 24 | -2.3% | 0.4% | ||
| Q3 24 | -0.3% | -79.1% | ||
| Q2 24 | -5.9% | -44.3% |
| Q1 26 | — | — | ||
| Q4 25 | 1.0% | -438.1% | ||
| Q3 25 | -8.4% | 246.4% | ||
| Q2 25 | -14.1% | 48.7% | ||
| Q1 25 | -18.6% | -400.5% | ||
| Q4 24 | -71.4% | 11.4% | ||
| Q3 24 | -101.2% | -104.2% | ||
| Q2 24 | -0.3% | -99.1% |
| Q1 26 | $0.27 | — | ||
| Q4 25 | $0.02 | $-6.94 | ||
| Q3 25 | $-0.16 | $7.27 | ||
| Q2 25 | $-0.28 | $1.12 | ||
| Q1 25 | $-0.34 | $-3.02 | ||
| Q4 24 | $-1.49 | $0.21 | ||
| Q3 24 | $-2.03 | $-0.67 | ||
| Q2 24 | $0.00 | $-1.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $41.0M | $80.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $133.9M | $69.4M |
| Total Assets | $179.4M | $112.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $41.0M | — | ||
| Q4 25 | $81.2M | $80.5M | ||
| Q3 25 | $80.2M | $176.2M | ||
| Q2 25 | $77.1M | $28.2M | ||
| Q1 25 | $75.4M | $18.9M | ||
| Q4 24 | $79.2M | $8.2M | ||
| Q3 24 | $90.7M | $7.2M | ||
| Q2 24 | $96.6M | $12.1M |
| Q1 26 | $133.9M | — | ||
| Q4 25 | $143.5M | $69.4M | ||
| Q3 25 | $146.8M | $210.2M | ||
| Q2 25 | $147.7M | $88.6M | ||
| Q1 25 | $148.4M | $42.4M | ||
| Q4 24 | $154.0M | $39.9M | ||
| Q3 24 | $179.9M | $38.3M | ||
| Q2 24 | $210.3M | $42.4M |
| Q1 26 | $179.4M | — | ||
| Q4 25 | $190.3M | $112.9M | ||
| Q3 25 | $189.4M | $223.4M | ||
| Q2 25 | $187.7M | $109.3M | ||
| Q1 25 | $190.6M | $52.3M | ||
| Q4 24 | $202.7M | $47.1M | ||
| Q3 24 | $231.4M | $43.4M | ||
| Q2 24 | $262.7M | $49.1M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $22.7M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $4.6M | $22.7M | ||
| Q3 25 | $6.9M | $-4.9M | ||
| Q2 25 | $-189.0K | $-353.0K | ||
| Q1 25 | $-130.0K | $1.2M | ||
| Q4 24 | $1.6M | $-16.7M | ||
| Q3 24 | $5.0M | $-4.7M | ||
| Q2 24 | $-1.1M | $1.4M |
| Q1 26 | — | — | ||
| Q4 25 | $4.0M | — | ||
| Q3 25 | $5.0M | — | ||
| Q2 25 | $-1.7M | — | ||
| Q1 25 | $-3.0M | — | ||
| Q4 24 | $275.0K | — | ||
| Q3 24 | $3.8M | — | ||
| Q2 24 | $-4.5M | — |
| Q1 26 | — | — | ||
| Q4 25 | 13.0% | — | ||
| Q3 25 | 17.9% | — | ||
| Q2 25 | -5.9% | — | ||
| Q1 25 | -11.3% | — | ||
| Q4 24 | 0.9% | — | ||
| Q3 24 | 12.9% | — | ||
| Q2 24 | -14.6% | — |
| Q1 26 | — | — | ||
| Q4 25 | 2.1% | — | ||
| Q3 25 | 6.8% | — | ||
| Q2 25 | 5.2% | — | ||
| Q1 25 | 10.8% | — | ||
| Q4 24 | 4.3% | — | ||
| Q3 24 | 4.1% | — | ||
| Q2 24 | 11.1% | — |
| Q1 26 | — | — | ||
| Q4 25 | 15.88× | — | ||
| Q3 25 | — | -0.04× | ||
| Q2 25 | — | -0.02× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -15.65× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ANIK
| OEM Channel | $17.0M | 57% |
| Commercial Channel | $12.6M | 43% |
DOMH
| Chief Operating Decision Maker | $30.1M | 100% |
| Commissions | $458.0K | 2% |
